Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Restructuring Costs (2024 - 2025)

Traws Pharma (TRAW) has disclosed Restructuring Costs for 2 consecutive years, with -$693000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Restructuring Costs rose 37.34% to -$693000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.7 million, a N/A change, with the full-year FY2024 number at $3.3 million, down 10.03% from a year prior.
  • Restructuring Costs was -$693000.0 for Q3 2025 at Traws Pharma, down from $545000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $2.6 million in Q1 2024 to a low of -$1.1 million in Q3 2024.